Phytel provides health care organizations with population health technology to deliver timely, coordinated care to their patients. The company’s registry uses evidence-based chronic and preventive care protocols to identify and notify patients due for care, while tracking compliance and measuring quality and financial results.
The company has built themselves to become “Best in KLAS” — according to that vendor research organization — the #1 Population Health SaaS company.
It’s been a privilege to have been their Board partner for the past four years.
The acquisition, once completed, will bolster IBM’s efforts to apply advanced analytics and cognitive computing to help primary care providers, large hospital systems and physician networks improve healthcare quality and effect healthier patient outcomes. The acquisition is subject to regulatory review and is anticipated to close later this year.
This announcement is significant for a number of reasons:
- First and foremost, a very important company was built by CEO Steve Schelhammer and his team. Steve is an incredible partner and Polaris repeat entrepreneur. All of the accolades Steve and his team have and will receive are well-deserved.
- The acquisition is testament to the convergence of robust Population Health Data, Actionable Analytics and thoughtfully-designed workflow-centric SaaS Healthcare solutions. Improving patient outcomes, maximizing care team effectiveness and managing risk of Providers and Payors alike have all been enabled by the marriage of data, technology, and domain expertise.
- In the world of payment reform, Phytel’s data registry of patients and physicians is central to the benchmarking of both outcomes and clinical performance. Phytel solutions in the areas of Patient Outreach, Population Analytics, Care Management, Patient Engagement and Care Transition have been both transformative as well as integral to a healthcare climate changing at breakneck speed.
Analytics which enable Value-Based Care.
Phytel will become a key part of IBM Watson Health, a dedicated business unit built around establishing Watson Health Cloud, also launched today. Designed to provide a secure, open platform for physicians, researchers, insurers and companies focused on health and wellness solutions, the HIPAA-enabled Cloud will enable secure access to individualized insights. And a more complete picture of the many factors that can affect people’s health.
IBM’s announcement at HIMSS today brings with it incredibly-exciting potential.
Phytel’s exceptional customer franchise of Health Care Organizations, its data assets and its industry expertise make it an extraordinary complement to the cognitive and predictive possibilities of IBM’s Watson Analytics and Cloud strategies.
We couldn’t be more pleased for the customers of Phytel and IBM. For Patients and Providers. And for Phytel’s employees and its leadership.